A citation-based method for searching scientific literature

Nicholas P Giustini, Ah-Reum Jeong, James Buturla, Lyudmila Bazhenova. Clin Chest Med 2020
Times Cited: 12







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
25


Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
16

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Thomas J Lynch, Daphne W Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A Okimoto, Brian W Brannigan, Patricia L Harris, Sara M Haserlat, Jeffrey G Supko, Frank G Haluska,[...]. N Engl J Med 2004
16

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, Didier Debieuvre, Jean Mosser, Hervé Lena, L'Houcine Ouafik, Benjamin Besse, Isabelle Rouquette, Virginie Westeel,[...]. Lancet 2016
551
16

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
Roy S Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, Alain Vergnenegre, Carlos H Barrios, Masahiro Morise, Enriqueta Felip, Zoran Andric, Sarayut Geater,[...]. N Engl J Med 2020
344
16

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols,[...]. Lancet 2017
16

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
16

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Matthew D Hellmann, Luis Paz-Ares, Reyes Bernabe Caro, Bogdan Zurawski, Sang-We Kim, Enric Carcereny Costa, Keunchil Park, Aurelia Alexandru, Lorena Lupinacci, Emmanuel de la Mora Jimenez,[...]. N Engl J Med 2019
16

Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells.
M L Marino, S Fais, M Djavaheri-Mergny, A Villa, S Meschini, F Lozupone, G Venturi, P Della Mina, S Pattingre, L Rivoltini,[...]. Cell Death Dis 2010
135
8


pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
Angelo De Milito, Rossella Canese, Maria Lucia Marino, Martina Borghi, Manuela Iero, Antonello Villa, Giulietta Venturi, Francesco Lozupone, Elisabetta Iessi, Mariantonia Logozzi,[...]. Int J Cancer 2010
182
8


Circular RNA ITCH: A novel tumor suppressor in multiple cancers.
Yang Li, Yu-Zheng Ge, Luwei Xu, Ruipeng Jia. Life Sci 2020
49
8


Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.
Kirsten Lindner, Christiane Borchardt, Maren Schöpp, Anja Bürgers, Christian Stock, Damian J Hussey, Jörg Haier, Richard Hummel. J Exp Clin Cancer Res 2014
41
8

Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Xu-Wen Guan, Fang Zhao, Jing-Ya Wang, Hai-Yan Wang, Shao-Hua Ge, Xia Wang, Le Zhang, Rui Liu, Yi Ba, Hong-Li Li,[...]. Am J Cancer Res 2017
23
8

lncRNA/circRNA‑miRNA‑mRNA ceRNA network in lumbar intervertebral disc degeneration.
Jinwen Zhu, Xinliang Zhang, Wenjie Gao, Huimin Hu, Xiaodong Wang, Dingjun Hao. Mol Med Rep 2019
64
8

Repositioning of proton pump inhibitors in cancer therapy.
Zhen-Ning Lu, Bing Tian, Xiu-Li Guo. Cancer Chemother Pharmacol 2017
35
8

FOXO3 Inhibits Human Gastric Adenocarcinoma (AGS) Cell Growth by Promoting Autophagy in an Acidic Microenvironment.
Yuan Gao, Weiwei Qi, Libin Sun, Jing Lv, Wensheng Qiu, Shihai Liu. Cell Physiol Biochem 2018
17
8

EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells.
Jing Cui, Wendong Sun, Xuexi Hao, Minli Wei, Xiaonan Su, Yajing Zhang, Ling Su, Xiangguo Liu. Cancer Cell Int 2015
42
8

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.
Ziyu Li, Xiaofang Xing, Fei Shan, Shuangxi Li, Zhongwu Li, Aitang Xiao, Zhaodong Xing, Kan Xue, Zhemin Li, Ying Hu,[...]. Oncotarget 2016
18
8

Long Noncoding RNA EGFR-AS1 Promotes Cell Proliferation by Increasing EGFR mRNA Stability in Gastric Cancer.
Jiaojiao Hu, Yingying Qian, Lipan Peng, Ling Ma, Tianzhu Qiu, Yiqian Liu, Xiao Li, Xiaofeng Chen. Cell Physiol Biochem 2018
28
8


Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment.
Tessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, Bart Kok, Sander R Piersma, Thang V Pham, Kenneth P Olive, Geert Kazemier, Hanneke W M van Laarhoven, Connie R Jimenez,[...]. Ther Adv Med Oncol 2019
18
8

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy.
Kenji Ikemura, Shunichi Hiramatsu, Masahiro Okuda. Front Pharmacol 2017
36
8

Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.
Yoshikazu Kinoshita, Norihisa Ishimura, Shunji Ishihara. J Neurogastroenterol Motil 2018
84
8

Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study.
Dingfeng Wu, Tianyi Qiu, Qingchen Zhang, Hong Kang, Shaohua Yuan, Lixin Zhu, Ruixin Zhu. Chem Res Toxicol 2015
13
8



Proton pump inhibitors: actions and reactions.
James M Mullin, Melissa Gabello, Lisa J Murray, Christopher P Farrell, Jillan Bellows, Kevin R Wolov, Keith R Kearney, David Rudolph, James J Thornton. Drug Discov Today 2009
57
8

GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.
Susann Kleinsimon, Enya Longmuss, Jana Rolff, Sebastian Jäger, Angelika Eggert, Catharina Delebinski, Georg Seifert. Sci Rep 2018
31
8

Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.
Elisabetta Iessi, Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Claudiu T Supuran, Stefano Fais. Metabolites 2017
41
8

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
8

Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer.
Jing He, Xiao-Yan Shi, Zhi-Min Li, Xiao-Hua Pan, Ze-Lian Li, Ying Chen, Shi-Jie Yan, Lan Xiao. BMC Mol Cell Biol 2019
17
8

Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway.
Xiaobin Shang, Guoyan Liu, Yuefeng Zhang, Peng Tang, Hongdian Zhang, Hongjing Jiang, Zhentao Yu. Oncol Lett 2018
22
8

Advances in the treatment of gastric cancer.
David H Ilson. Curr Opin Gastroenterol 2017
24
8

Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chih-Cheng Chen, Chia-Bao Chu, Ko-Jiunn Liu, Chi-Ying F Huang, Jang-Yang Chang, Wen-Yu Pan, Huang-Hui Chen, Yun-Hsia Cheng, Kuan-Der Lee, Miao-Fen Chen,[...]. Biochem Pharmacol 2013
36
8

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
Lei Guo, Shumin Zhang, Bo Zhang, Wanyong Chen, Xiaoqiang Li, Wentao Zhang, Chenhao Zhou, Jubo Zhang, Ning Ren, Qinghai Ye. Cell Biol Toxicol 2016
27
8


Role of miR-647 in human gastric cancer suppression.
Wenlong Cao, Weiyuan Wei, Zexu Zhan, Dongyi Xie, Yubo Xie, Qiang Xiao. Oncol Rep 2017
24
8

Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells.
Wentao Qi, Christopher R Weber, Kaarin Wasland, Hemant Roy, Ramesh Wali, Suhasini Joshi, Suzana D Savkovic. Am J Physiol Gastrointest Liver Physiol 2011
22
8


Comprehensive analysis of differentially expressed non-coding RNAs and mRNAs in gastric cancer cells under hypoxic conditions.
Jia Li, Xinjing Wang, Wenli Lu, Yuan Xiao, Yi Yu, Xinqiong Wang, Chundi Xu, Baiyong Shen. Am J Transl Res 2018
5
20

Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
Bin Zhang, Tingsheng Ling, Panduo Zhaxi, Yu Cao, Liping Qian, Dian Zhao, Wei Kang, Weijie Zhang, Lei Wang, Guifang Xu,[...]. Cancer Lett 2019
8
12

Homeodomain-interacting protein kinase promotes tumorigenesis and metastatic cell behavior.
Jessica A Blaquiere, Kenneth Kin Lam Wong, Stephen D Kinsey, Jin Wu, Esther M Verheyen. Dis Model Mech 2018
15
8



Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Ruiping Wang, Shumei Song, Kazuto Harada, Fatemeh Ghazanfari Amlashi, Brian Badgwell, Melissa Pool Pizzi, Yan Xu, Wei Zhao, Xiaochuan Dong, Jiangkang Jin,[...]. Gut 2020
40
8

The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses.
Yu Cao, Min Chen, Dehua Tang, Hongli Yan, Xiwei Ding, Fan Zhou, Mingming Zhang, Guifang Xu, Weijie Zhang, Shu Zhang,[...]. Cell Death Dis 2018
12
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.